IBAB Ion Beam Applications SA

IBA is looking for 100 new collaborators in Belgium by June 2023

IBA is looking for 100 new collaborators in Belgium by June 2023

Louvain-la-Neuve, Belgium, 14 March 2023  - (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology wants to hire 100 new employees during the first half of 2023. Among the actions undertaken to achieve this goal, the company is organizing a special recruitment evening, "Meet & Join IBA", in Louvain-la-Neuve on March 28. Interested parties are invited to register on the Forem website.

For more than 35 years, IBA has been designing, producing, and marketing innovative solutions for the diagnosis and treatment of cancer and other serious diseases, as well as industrial applications in the field of sterilization. As a world leader in particle accelerator technology, with an order backlog of more than EUR 1 billion, the company supplies thousands of hospitals and healthcare companies around the world with its accelerators, medical devices and applications for proton therapy, nuclear medicine, sterilization, and dosimetry. 

IBA, which currently employs more than 1,800 people (including 900 in Belgium) in more than 40 countries, wants to recruit 100 additional employees in Louvain-la-Neuve by June 2023.

Talents sought? IT, scientific, technical and management profiles

Many profiles are sought to meet the growth of the company's various activities: software developers, R&D project managers, automation engineers, data engineers, buyers, fitters, qualification & validation engineers, electromechanical engineers, hardware engineers, etc.

Special recruitment evening on March 28 in Louvain-la-Neuve at IBA

Candidates interested in the offers are invited to discover the company and the jobs during the "Meet & Join IBA" event organized by IBA in collaboration with Forem. This special evening will be an opportunity for candidates to meet their future colleagues while immersing themselves in the unique environment and culture of this international Walloon company. To participate, simply consult IBA's job offers on the Forem website, check the required skills, and fill in the registration form corresponding to the selected position(s).  Registration is open until March 26 and is mandatory.

“Meet & Join IBA” with the collaboration of Forem

Tuesday, March 28 from 5.30 to 9.00 PM

Chemin du Cyclotron 3, 1348 Ottignies-Louvain-la-Neuve

Program:

  • 5.30 > 6 PM: Reception
  • 6 > 6.20 PM: IBA Presentation 
  • 6.20 > 6.30 PM: Question & answer session
  • 6.30 > 7.15 PM: Guided tour of the assembly hall
  • 7.15 > 9 PM: Drink & networking

News and inscriptions:

*** Ends ***

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

For further information, please contact:

IBA

Olivier Lechien

Corporate Communication Director



Attachment



EN
14/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE

IBA – TRANSPARENCY NOTIFICATION

IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 25, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 13, 2026. In its notification, Premier Miton Group plc indi...

 PRESS RELEASE

IBA SA – NOTIFICATION TRANSPARENCE

IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 25 février 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir effectuer une notification en matière de transparence conformément à l'article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes (« loi transparence »), à la suite d’une notification reçue le ...

 PRESS RELEASE

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, February 23rd, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026. Under this program, IBA has requested a financial intermediary to repurchase up to 400,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until September 30th, 2026 (included), effective as from February 3rd, 20...

 PRESS RELEASE

IBA – ACQUISITION D’ACTIONS PROPRES

IBA – ACQUISITION D’ACTIONS PROPRES Louvain-la-Neuve, Belgique, 23 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 2 février 2026. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 400.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 30 septembre 2026 et effectif à part...

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HY...

: ABI BB, AGN NA, ARCAD NA, BESI NA, ENX FP, GIMB BB, HYL BB, IBAB BB, KIN BB, MTLS US, VGP BB, AZE BB, ZEAL DC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch